Novel And Powerful Mhc-Class Ii Petptides Derived From Survivin

Patent No. EP2291395 (titled "Novel And Powerful Mhc-Class Ii Petptides Derived From Survivin") was filed by Immatics Biotechnologies on May 14, 2009. The application was issued on Nov 14, 2018.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GEVERS & ORESMay 12, 2016GEVERS & ORES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2291395

IMMATICS BIOTECHNOLOGIES
Application Number
EP09745570A
Filing Date
May 14, 2009
Status
Patent Maintained As Amended
Oct 12, 2018
Publication Date
Nov 14, 2018